Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review
Chih-Cheng Lai, Jui-Hsiang Wang, Po‐Ren Hsueh
International Journal of Infectious Diseases (2020) Vol. 101, pp. 314-322
Open Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)
Simone Cesaro, Per Ljungman, Małgorzata Mikulska, et al.
Leukemia (2022) Vol. 36, Iss. 6, pp. 1467-1480
Open Access | Times Cited: 105
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
N. Ahmad Aziz, Victor M. Corman, Antje K. C. Echterhoff, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 89
Applications of Raman Spectroscopy in Bacterial Infections: Principles, Advantages, and Shortcomings
Liang Wang, Wei Liu, Jia-Wei Tang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 81
Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis
Ahmed Hossain, Sarker Mohammad Nasrullah, Zarrin Tasnim, et al.
EClinicalMedicine (2021) Vol. 33, pp. 100770-100770
Open Access | Times Cited: 77
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis
Master Chisale, Sheena Ramazanu, Saul Eric Mwale, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 77
SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru
Mary F. Reyes, Mirtha Gabriela Soto Cabezas, Fanny Cárdenas, et al.
EClinicalMedicine (2021) Vol. 34, pp. 100801-100801
Open Access | Times Cited: 71
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021.
Wendy Sykes, Laurette Mhlanga, Ronél Swanevelder, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 69
High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya
Isaac Ngere, Jeanette Dawa, Elizabeth Hunsperger, et al.
International Journal of Infectious Diseases (2021) Vol. 112, pp. 25-34
Open Access | Times Cited: 57
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies
Maher A. Sughayer, Lina Souan, Maha M. Abu Alhowr, et al.
Vaccine (2022) Vol. 40, Iss. 20, pp. 2841-2847
Open Access | Times Cited: 44
Prevalence of SARS-Cov-2 antibodies and living conditions: the French national random population-based EPICOV cohort
Josiane Warszawski, Anne-Lise Beaumont, Rémonie Seng, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 37
Fundamental Identifiability Limits in Molecular Epidemiology
Stilianos Louca, Angela McLaughlin, Ailene MacPherson, et al.
Molecular Biology and Evolution (2021) Vol. 38, Iss. 9, pp. 4010-4024
Open Access | Times Cited: 44
Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile
Pablo Vial, Claudia González, Gloria Icaza, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Determinants and dynamics of the seroprevalence of anti‐SARS‐CoV‐2 antibodies in Poland
Justyna Adamczuk, Karol Kamiński, Sebastian Sołomacha, et al.
Advances in Medical Sciences (2025)
Closed Access
Seroepidemiological study of SARS-CoV-2 infection in East Java, Indonesia
Ni Luh Ayu Megasari, Takako Utsumi, Laura Navika Yamani, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251234-e0251234
Open Access | Times Cited: 38
Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020–December 2020
Patrick S. Sullivan, Aaron J. Siegler, Kayoko Shioda, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 7, pp. 1141-1150
Open Access | Times Cited: 36
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
Aude Richard, Ania Wisniak, Javier Perez‐Saez, et al.
Scandinavian Journal of Public Health (2021) Vol. 50, Iss. 1, pp. 124-135
Open Access | Times Cited: 34
Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation
А. Yu. Popova, E.E. Andreeva, E.A. Babura, et al.
Russian Journal of Infection and Immunity (2021) Vol. 11, Iss. 2, pp. 297-323
Open Access | Times Cited: 33
Cold and dry winter conditions are associated with greater SARS-CoV-2 transmission at regional level in western countries during the first epidemic wave
Jordi Landier, Juliette Paireau, Stanislas Rebaudet, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 33
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis
Nuzrath Jahan, Adarsha Brahma, Muthusamy Santhosh Kumar, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 59-67
Open Access | Times Cited: 33
Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure
Alexis R. Demonbreun, Thomas W. McDade, Lorenzo L. Pesce, et al.
JCI Insight (2021) Vol. 6, Iss. 9
Open Access | Times Cited: 32
Saliva SARS-CoV-2 Antibody Prevalence in Children
Maya W. Keuning, Marloes Grobben, A Groen, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 32
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland
Hélène Baysson, Francesco Pennacchio, Ania Wisniak, et al.
BMJ Open (2022) Vol. 12, Iss. 1, pp. e055515-e055515
Open Access | Times Cited: 25
Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study
Marcela Mercado, Jeadran Malagón-Rojas, Isabel Rodríguez-Barraquer, et al.
The Lancet Regional Health - Americas (2022) Vol. 9, pp. 100195-100195
Open Access | Times Cited: 25
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Sandra Gofinet Pasoto, et al.
The Lancet Rheumatology (2021) Vol. 4, Iss. 2, pp. e113-e124
Open Access | Times Cited: 31
From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany)
Katja Radon, Abhishek Bakuli, Peter Pütz, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top